A Pilot Study to Evaluate the Safety and Efficacy of an Oral Dose of (−)-Epigallocatechin-3-Gallate–Rich Polyphenon E in Patients With Mild to Moderate Ulcerative Colitis

Proinflammatory Cytokines in the Pathogenesis of Inflammatory Bowel Diseases

(2011) Warren Strober et al.   GASTROENTEROLOGY

Green tea polyphenol epigallocatechin-3-gallate shows therapeutic antioxidative effects in a murine model of colitis

(2011) Markus Brückner et al.   Journal of Crohns & Colitis

Green tea EGCG, T cells, and T cell-mediated autoimmune diseases

(2011) Dayong Wu et al.   MOLECULAR ASPECTS OF MEDICINE

Risk Factors for Neoplasia in Inflammatory Bowel Disease Patients With Pancolitis

(2010) Vivianne Bergeron et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

AGA Technical Review on the Diagnosis and Management of Colorectal Neoplasia in Inflammatory Bowel Disease

(2010) Francis A. Farraye et al.   GASTROENTEROLOGY

Green tea polyphenol epigallocatechin gallate inhibits cell signaling by inducing SOCS1 gene expression

(2010) B. J. M. Ripley et al.   INTERNATIONAL IMMUNOLOGY

Laboratory, Epidemiological, and Human Intervention Studies Show That Tea (Camellia sinensis) May Be Useful in the Prevention of Obesity

(2010) Kimberly A. Grove et al.   JOURNAL OF NUTRITION

Green tea polyphenol epigallocatechi3-gallate: Inflammation and arthritis

(2010) Rashmi Singh et al.   LIFE SCIENCES

Epigallocatechin gallate–mediated protection against tumor necrosis factor-α–induced monocyte chemoattractant protein–1 expression is heme oxygenase–1 dependent

(2010) Yuanyuan Zheng et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Multitargeted therapy of cancer by green tea polyphenols

(2008) Naghma Khan et al.   CANCER LETTERS

Therapeutic effect of epigallocatechin-3-gallate in a mouse model of colitis

(2007) Patricia A. Abboud et al.   EUROPEAN JOURNAL OF PHARMACOLOGY